Skip to main content
Log in

GBS screening before Caesarean delivery may be cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 US dollars

Reference

  • Albright CM, et al. Group B Streptococci Screening Before Repeat Cesarean Delivery: A Cost-Effectiveness Analysis. Obstetrics and Gynecology : 2 Dec 2016. Available from: URL: http://doi.org/10.1097/AOG.0000000000001800

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

GBS screening before Caesarean delivery may be cost effective. PharmacoEcon Outcomes News 769, 14 (2017). https://doi.org/10.1007/s40274-017-3650-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3650-3

Navigation